EP1888100
Notkun á IL-18BP ísóformum til meðhöndlunar og/eða fyrirbyggingar á taugrænum bólgusjúkdómum.
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.6.2006EP published:
26.10.2011EP application number:
06763485.7
EP translation filed:
28.12.2011Grant published:
15.1.2012EPO information:
European Patent Register
Max expiry date:
1.6.2026Expiry date:
1.6.2026
Title:
USE OF IL-18BP ISOFORMS FOR THE TREATMENT AND/OR PREVENTION OF NEUROLOGICAL INFLAMMATORY DISEASES
Timeline
Owner
Name:
Merck Serono SAAddress:
Centre Industriel, 1267, Coinsins, Vaud, CH
Inventor
Name:
SAGOT, YvesAddress:
Beaumont, FR
Name:
CHVATCHKO, YolandeAddress:
Confignon, CH
Name:
CORBAZ, AnneAddress:
Lausanne, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
05104863Date:
3.6.2005Country:
EP
Number:
688057 PDate:
7.6.2005Country:
US
Classification
Categories:
A61P 25/00, A61K 38/17
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 8.5.2012
Expires: 1.6.2013
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 8.5.2013
Expires: 1.6.2014
Payer: Árnason Faktor
Number: 9
Paid: 7.5.2014
Expires: 1.6.2015
Payer: Árnason Faktor
Number: 10
Paid: 7.5.2015
Expires: 1.6.2016
Payer: Árnason Faktor
Number: 11
Paid: 10.5.2016
Expires: 1.6.2017
Payer: Árnason Faktor
Number: 12
Paid: 8.5.2017
Expires: 1.6.2018
Payer: Árnason Faktor
Number: 13
Paid: 14.5.2018
Expires: 1.6.2019
Payer: Árnason Faktor
Number: 14
Paid: 8.5.2019
Expires: 1.6.2020
Payer: Árnason Faktor
Number: 15
Paid: 5.5.2020
Expires: 1.6.2021
Payer: Árnason Faktor ehf.
Number: 16
Paid: 11.5.2021
Expires: 1.6.2022
Payer: Árnason Faktor ehf.
Number: 17
Paid: 6.5.2022
Expires: 1.6.2023
Payer: Árnason Faktor ehf.
Number: 18
Paid: 24.5.2023
Expires: 1.6.2024
Payer: Árnason Faktor ehf.
Number: 19
Paid: 7.5.2024
Expires: 1.6.2025
Payer: Árnason Faktor ehf.
Number: 20
Paid: 30.5.2025
Expires: 1.6.2026
Payer: Árnason Faktor ehf.